retatrutide how often to take Injection: Package Insert / Prescribing Info Retatrutide Dosing Guide for Researchers

In June 2023, Lilly announced that Retatrutide achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight and a mean weight reduction up to 24.2% at 48 weeks during phase II studies

The trial showed that tirzepatide achieved roughly 20% weight loss (about 50 pounds) versus 14% weight loss (33 pounds) with semaglutide. This significant difference prompted analysts to declare tirzepatide the winner. As a result, clinicians are updating treatment algorithms and patients on semaglutide are asking about switching

This unique mechanism makes it one of the most promising compounds for comprehensive metabolic regulation, supporting blood sugar balance, appetite suppression, fat loss, and potential lean muscle preservation

Compounded GLP-1 medications are not generic versions of FDA-approved drugs and are not intended to be substitutes for FDA-approved products